aXichem receives order form CHR. Olesen for ten tons of aXiphen[®] to be delivered during the second quarter this year
aXichem AB (publ), that develops and markets natural analogue industrial compounds, has obtained an order from its distributor CHR. Olesen for ten tons of the product aXiphen, to be delivered to animal feed producers in Europe. The total value of the order from CHR. Olesen amounts to 2 million SEK. The order will be delivered during the second quarter this year.
In December 2020 aXichem announced that the company’s natural analogue capsaicin, aXiphen, had been evaluated as a feed ingredient and used in 80 chicken production plants in the Netherlands. The evaluation was carried out under the collaboration agreement with the distributor CHR. Olesen and has shown very positive results. The order of ten tons is the largest order in aXichem’s history so far and is a result of CHR. Olesen’s work in the Netherlands among other countries.
– This is a significant mile stone in aXichem’s commercial establishment of aXiphen. I’m very pleased of how the collaboration with CHR. Olesen is developing and I am looking forward to the continued marketing activities in Europe, says Torsten Helsing, CEO of aXichem.
About aXiphen®
aXiphen® is a natural analogue substance, a synthetically produced and patented capsacin, based on a molecule developed by aXiphen®. Since aXiphen® is synthetically produced the substance has a number of advantages compared to natural capsaicin. The main difference is that natural capsaicin is extracted from chili and therefore varies in quality and seldom reaches a concentration above 85 percent. aXiphen® holds a concentration of at least 97 percent and has predictable characteristics. One of the key industrial benefits of aXiphen® is that aXichem can determine its water- and fat solubility, which is critical when using the substance in various kinds of products.
This press release has been translated from Swedish. The Swedish text shall govern for all purposes and prevail in case of any discrepancy with the English version.
Torsten Helsing, CEO aXichem, Ph + 46 46-780 06 73. E-mail: torsten.helsing@axichem.se
aXichem’s business idea is to develop, patent and market natural analogue industrial compounds. The Company primarily works with phenylcapsaicin a structural analogue of capsaicin with a wide range of applications, such as feed additives, marine anti-fouling products and certain pharmaceutical areas. aXichem’s shares are listed on NASDAQ First North Growth Market under AXIC A. Certified Adviser: Redeye AB Certifiedadviser@redeye.se +46 (0)8 121 576 90. Read more about the company at www.axichem.se